Theravance Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TBPH and other ETFs, options, and stocks.

About TBPH

Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the U.S. and Europe geographical segments. 

CEO
Rick E. Winningham
CEORick E. Winningham
Employees
97
Employees97
Headquarters
South San, California
HeadquartersSouth San, California
Founded
2013
Founded2013
Employees
97
Employees97

TBPH Key Statistics

Market cap
895.89M
Market cap895.89M
Price-Earnings ratio
31.31
Price-Earnings ratio31.31
Dividend yield
Dividend yield
Average volume
465.55K
Average volume465.55K
High today
$17.92
High today$17.92
Low today
$17.28
Low today$17.28
Open price
$17.72
Open price$17.72
Volume
807.79K
Volume807.79K
52 Week high
$20.33
52 Week high$20.33
52 Week low
$7.90
52 Week low$7.90

Stock Snapshot

The current Theravance Biopharma(TBPH) stock price is $17.75, with a market capitalization of 895.89M. The stock trades at a price-to-earnings (P/E) ratio of 31.31.

On 2025-12-12, Theravance Biopharma(TBPH) stock moved within a range of $17.28 to $17.92. With shares now at $17.75, the stock is trading +2.7% above its intraday low and -0.9% below the session's peak.

Trading activity shows a volume of 807.79K, compared to an average daily volume of 465.55K.

Over the past 52 weeks, Theravance Biopharma(TBPH) stock has traded between a high of $20.33 and a low of $7.90.

Over the past 52 weeks, Theravance Biopharma(TBPH) stock has traded between a high of $20.33 and a low of $7.90.

TBPH News

TipRanks 2d
Theravance Biopharma’s Ampreloxetine: A Promising Candidate for Neurogenic Orthostatic Hypotension with Strong Market Potential

Analyst Julian Harrison of BTIG maintained a Buy rating on Theravance Biopharma, retaining the price target of $40.00. TipRanks Cyber Monday Sale Claim 60% off...

Analyst ratings

71%

of 7 ratings
Buy
71.4%
Hold
28.6%
Sell
0%

People also own

Based on the portfolios of people who own TBPH. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.